Suppr超能文献

国家眼科研究所大胆目标计划报告:利用内源性细胞来源替换视网膜神经节细胞

Report on the National Eye Institute Audacious Goals Initiative: Replacement of Retinal Ganglion Cells from Endogenous Cell Sources.

作者信息

Vetter Monica L, Hitchcock Peter F

机构信息

Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT, USA.

Department of Neurobiology and Anatomy, University of Utah, Salt Lake City, UT, USA ; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, MI, USA.

出版信息

Transl Vis Sci Technol. 2017 Mar 15;6(2):5. doi: 10.1167/tvst.6.2.5. eCollection 2017 Mar.

Abstract

This report emerges from a workshop convened by the National Eye Institute (NEI) as part of the "Audacious Goals Initiative" (AGI). The workshop addressed the replacement of retinal ganglion cells (RGCs) from exogenous and endogenous sources, and sought to identify the gaps in our knowledge and barriers to progress in devising cellular replacement therapies for diseases where RGCs die. Here, we briefly review relevant literature regarding common diseases associated with RGC death, the genesis of RGCs in vivo, strategies for generating transplantable RGCs in vitro, and potential endogenous cellular sources to regenerate these cells. These topics provided the clinical and scientific context for the discussion among the workshop participants and are relevant to efforts that may lead to therapeutic approaches for replacing RGCs. This report also summarizes the content of the workshop discussion, which focused on: (1) cell sources for RGC replacement and regeneration, (2) optimizing integration, survival, and synaptogenesis of new RGCs, and (3) approaches for assessing the outcomes of RGC replacement therapies. We conclude this report with a summary of recommendations, based on the workshop discussions, which may guide vision scientists seeking to develop therapies for replacing RGCs in humans.

摘要

本报告源自美国国立眼科研究所(NEI)召开的一次研讨会,该研讨会是“大胆目标倡议”(AGI)的一部分。此次研讨会探讨了从外源性和内源性来源替换视网膜神经节细胞(RGCs)的问题,并试图找出我们在设计针对RGCs死亡疾病的细胞替代疗法方面的知识空白和进展障碍。在此,我们简要回顾有关与RGCs死亡相关常见疾病、RGCs在体内的起源、体外生成可移植RGCs的策略以及再生这些细胞的潜在内源性细胞来源的相关文献。这些主题为研讨会参与者之间的讨论提供了临床和科学背景,并且与可能导致RGCs替代治疗方法的研究工作相关。本报告还总结了研讨会讨论的内容,重点关注:(1)RGCs替代和再生的细胞来源;(2)优化新RGCs的整合、存活和突触形成;(3)评估RGCs替代疗法结果的方法。我们根据研讨会讨论内容总结了建议,以此结束本报告,这些建议可能会指导视觉科学家寻求开发用于人类RGCs替代的疗法。

相似文献

引用本文的文献

1
Therapeutic strategies for glaucoma and optic neuropathies.青光眼和视神经病变的治疗策略。
Mol Aspects Med. 2023 Dec;94:101219. doi: 10.1016/j.mam.2023.101219. Epub 2023 Oct 13.
4
On the Generation and Regeneration of Retinal Ganglion Cells.视网膜神经节细胞的生成与再生
Front Cell Dev Biol. 2020 Sep 17;8:581136. doi: 10.3389/fcell.2020.581136. eCollection 2020.
6
Gene expression in retinal ischemic post-conditioning.视网膜缺血后处理中的基因表达。
Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):935-949. doi: 10.1007/s00417-018-3905-0. Epub 2018 Mar 5.

本文引用的文献

1
Reconnecting Eye to Brain.让眼睛与大脑重新相连。
J Neurosci. 2016 Oct 19;36(42):10707-10722. doi: 10.1523/JNEUROSCI.1711-16.2016.
5
Visual task performance in the blind with the BrainPort V100 Vision Aid.使用BrainPort V100视觉辅助设备的盲人的视觉任务表现。
Expert Rev Med Devices. 2016 Oct;13(10):919-931. doi: 10.1080/17434440.2016.1237287. Epub 2016 Oct 5.
6
Induced Pluripotent Stem Cells: Development in the Ophthalmologic Field.诱导多能干细胞:眼科领域的发展
Stem Cells Int. 2016;2016:2361763. doi: 10.1155/2016/2361763. Epub 2016 Aug 10.
7
Public Attitudes About Eye and Vision Health.公众对眼睛和视力健康的态度。
JAMA Ophthalmol. 2016 Oct 1;134(10):1111-1118. doi: 10.1001/jamaophthalmol.2016.2627.
9
Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.视神经病变中的新兴线粒体治疗靶点。
Pharmacol Ther. 2016 Sep;165:132-52. doi: 10.1016/j.pharmthera.2016.06.004. Epub 2016 Jun 8.
10
Retina regeneration in zebrafish.斑马鱼的视网膜再生
Curr Opin Genet Dev. 2016 Oct;40:41-47. doi: 10.1016/j.gde.2016.05.009. Epub 2016 Jun 6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验